Jack Allen
Stock Analyst at Baird
(3.23)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
VOR Vor Biopharma | Maintains: Neutral | 1 1 | 1.81 | -44.75% | 4 | Jun 27, 2025 | |
FATE Fate Therapeutics | Maintains: Neutral | 5 4 | 1.02 | 292.16% | 2 | May 14, 2025 | |
ALLO Allogene Therapeutic... | Maintains: Outperform | 12 9 | 1.17 | 669.23% | 3 | May 14, 2025 | |
CARM CARISMA Therapeutics | Downgrades: Neutral | 10 1 | n/a | n/a | 3 | Dec 12, 2024 | |
INKT MiNK Therapeutics | Maintains: Outperform | 80 40 | 15.04 | 165.96% | 2 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 77 106 | 77.68 | 36.46% | 5 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 18 | 11.42 | 57.62% | 2 | Oct 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 180 180 | 23.8 | 656.3% | 9 | Sep 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 140 120 | 4.97 | 2314.49% | 3 | Aug 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 8 | 1.82 | 339.56% | 1 | Jun 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 46 52 | 55.89 | -6.96% | 2 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 84 | 36.57 | 129.7% | 1 | Oct 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 200 25 | n/a | n/a | 3 | Sep 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 8 | 3.24 | 146.91% | 4 | Aug 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 21 6 | 4.91 | 6.92% | 2 | Aug 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 5 | 1.3 | 284.62% | 1 | Nov 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 9 | 3.2 | 181.25% | 1 | Sep 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | May 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 6 9 | 4.38 | 105.48% | 1 | Oct 7, 2021 |